Buy Gsk Shares [RECOMMENDED]

: Settled ~93% (80,000 cases) of U.S. Zantac litigation for $2.2 billion, removing a major long-term overhang. ⚠️ Risks to Consider Stock Story: GSK - The Merchants Trust

: Strong market position with Shingrix (shingles) and Arexvy (RSV). buy gsk shares

: Five major product approvals were achieved in 2025; two more expected in 2026 for bepirovirsen and tebipenem . : Settled ~93% (80,000 cases) of U

: Trades at ~10.3x to 14.5x 2026 adjusted earnings. : Settled ~93% (80

: Specialty medicines (HIV, Oncology, Respiratory) now drive over 40% of revenue.